Latest Press Release: 27th February 2017
Congenica raises £8M ($10M) in Series B financing round to drive international expansion of its genome analysis business
CAMBRIDGE, UK – 27 February, 2017 – Congenica, a leading provider of clinical genome analysis technology, announced today that it has raised £8m ($10m) in its Series B financing round. Existing investors, Cambridge Innovation Capital plc (CIC) and Amadeus Capital Partners (Amadeus) participated alongside new investor, Parkwalk Advisors (Parkwalk). Congenica will use the Series [...]
Press Release: 14th April 2015
Congenica Genome Diagnostic Company Raises £2.2m
Amadeus Capital Partners and Cambridge Innovation Capital invest Tuesday 14 April Cambridge-based Congenica, a spinout from The Wellcome Trust Sanger Institute, has raised a further £2.2m with the completion of a series A round of financing by Amadeus Capital Partners’ early stage funds and the company’s initial investor Cambridge Innovation Capital. Congenica was [...]